posdinemab

News

Hopes that anti-tau drugs could emerge as treatments for Alzheimer's have been dented by the failure of a phase 2b trial of J&J's posdinemab.

News

Amazon Web Services has committed $100m in AI and cloud technology capacity to support the building of health services for "underserved communities."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.